MEDI-0618 | Interleukin Related interleukin-related.com

Product Name :
MEDI-0618

Search keywords :
PAR2

drugId :
null

Target Vo:
Protease-activated receptor-2

Target Vo Short Name :
PAR-2

Moa_Name:
Protease-activated receptor-2antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Astrazeneca Plc

Active Company_Name :
Astrazeneca Plc

Active Indication_Name:
Chronic Pain

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
xCT Antibody (YA652)
PDCD4 Antibody
MMP9 Antibody: MMP9 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 78 kDa, targeting to MMP9. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts